The ePRO debate is over: It’s now well known that electronic patient reporting reduces burden and delivers more real-time data. But, not all ePRO is created equal. To ensure you get the most accurate outcomes possible, you need ePRO designed by digital experts—and purpose-built for ease.Schedule a Demo
Today’s ePRO offerings are too often digitized versions of poor traditional assessments. Upgrade your clinical trial with ObvioHealth’s ePRO—purpose-built for digital and designed to deliver better data, faster.
Ditch device provisioning. Our BYOD ePRO model integrates seamlessly into patients’ lives, allowing them to report using their own mobile devices.
Our patient experience is specifically designed for ease, with user-friendly scales and interactive functions that make data capture quick and intuitive.
Automated alerts, notifications, and reminders are built in to boost compliance, supported by gamification that keeps participants engaged from start to finish.
Our cloud-based, modular platform and app deliver so much more than just ePRO made easy. ObvioGo streamlines and optimizes data collection, assessment, and management processes to deliver the accuracy you need—and success at every touchpoint.
Latest ePRO Innovation
The subjectivity that characterizes ePRO can be challenging to overcome, compromising data accuracy and trial endpoints. We’ve responded to this industry-wide problem with a practical solution: Augmented ePRO. Our breakthrough offer combines the ease of ePRO with the accuracy of expert rating, all centralized into a single platform.
AI-assisted image capture capabilities built into the ObvioGo app guide patients and enable them to snap and send high-quality images and videos with just a couple of taps on their mobile devices.
Patients can effortlessly capture and upload acoustic data using the ObvioGo app on their mobile devices, or external devices can easily be linked directly to the app for continuous ambient recording.
Expert rater workflows are streamlined and integrated into our unified platform—where high-quality media outcomes, collected by patients, are aggregated, delegated, and ready to rate.
ObvioHealth recently completed the first-ever fully virtual urogynecology study to evaluate a medical digital intravaginal device for female stress urinary incontinence. In this randomized trial, pelvic floor muscle contractions were monitored while subjects were completing at-home Kegel exercises. The wand-like device collected data and wirelessly transferred it to a smartphone app downloaded at the start of the study. While there had been initial concerns that older participants might be intimidated by the technology, the results of the study showed that women aged 65 and older had higher rates of completion versus their younger counterparts.